Strata Critical Medical (SRTA) Stock Statistics & Valuation Metrics

Strata Critical Medical has a market cap or net worth of $434.36M. The enterprise value is $322.32.

Strata Critical Medical has 86,526,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Strata Critical Medical’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is -7.30%.

The current PE Ratio of Strata Critical Medical is ―. Strata Critical Medical’s PEG ratio is 0.55.

In the last 12 months, Strata Critical Medical had revenue of 197.14M and earned 41.35M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was -27.02M and capital expenditures -18.28M, giving a free cash flow of -45.30M billion.

Strata Critical Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Strata Critical Medical upcoming earnings date is Nov 11, 2026, After Close (Confirmed).

Strata Critical Medical as a current ratio of 6.38, with Debt / Equity ratio of 1.52%

In the past 12 months, Strata Critical Medical has paid 0.00 in taxes.

Strata Critical Medical EV to EBITDA ratio is -64.63, with an EV/FCF ratio of -6.16.

Strata Critical Medical has $22.75M in cash and marketable securities with $4.25M in debt, giving a net cash position of $18.50M billion.

Gross margin is 20.56%, with operating margin of -11.34%, and net profit margin of 20.97%.

The average price target for Strata Critical Medical is $9.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy